Simbionix Increases Product Offerings for OB/GYN Physicians

CLEVELAND and ZURICH, Switzerland - Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons
the Most Advanced Training System for Endoscopic Surgery

Shire Announces Launch of FOSRENOL(R) in Japan

DUBLIN - Availability of Non-Calcium, Non-Resin FOSRENOL(R) Gives New
Therapy Choice for the Management of Hyperphosphataemia in End-Stage Renal
Disease Patients(1) in Japan

Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease

EINDHOVEN, The Netherlands - The Center for Translational Molecular Medicine (CTMM) - the Dutch
public-private partnership committed to the research and development of new
techniques for the diagnosis and treatment of major diseases - today
announced that eight new research projects will receive funding from the
CTMM. It means that almost 250 million Euros have now been allocated to
Netherlands-based translational projects that could radically improve patient
outcomes for diseases such as Alzheimer’s, rheumatoid arthritis, sepsis,
cardiovascular disorders and the most important forms of cancer.